Ti Jun Yu
Director/Miembro de la Junta en Shanghai Mingyuan Enterprise Group Co. Ltd. .
Perfil
Ti Jun Yu is currently serving as the Vice Chairman at Eastern China Health Education Research Society.
Additionally, he holds the position of Director & Vice President at Shanghai Mingyuan Enterprise Group Co. Ltd.
since 2010.
He is also the Executive Director & Vice President-Corporate at China Association of Health Education since 2011 and the Vice President at Shanghai Corporate Health Management Promotion Committee.
Previously, Mr. Yu worked as a Non-Executive Director at Mingyuan Medicare Development Co. Ltd.
from 2004 to 2016.
Cargos activos de Ti Jun Yu
Empresas | Cargo | Inicio |
---|---|---|
Shanghai Mingyuan Enterprise Group Co. Ltd. | Director/Miembro de la Junta | 19/03/2010 |
China Association of Health Education | Director/Miembro de la Junta | 19/03/2010 |
Eastern China Health Education Research Society | Director/Miembro de la Junta | 19/03/2010 |
Shanghai Corporate Health Management Promotion Committee | Corporate Officer/Principal | - |
Antiguos cargos conocidos de Ti Jun Yu.
Empresas | Cargo | Fin |
---|---|---|
MINGYUAN MEDICARE DEVELOPMENT CO., LTD. | Director/Miembro de la Junta | 20/05/2016 |
Experiencias
Funciones ocupadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas privadas | 5 |
---|---|
Mingyuan Medicare Development Co. Ltd.
Mingyuan Medicare Development Co. Ltd. BiotechnologyHealth Technology Mingyuan Medicare Development Co. Ltd. engages in provision of medicare solutions for the early detection and prevention of diseases particularly in China. It operates through the following segments: Protein Chips, Healthcare, Medical Centers Management, Individualized Target Therapy, and Bio-Drugs. The Protein Chips segment manufactures and distributes C-12 products to hospitals, medical centers, and life insurance companies in China. The Healthcare segment engages in the provision of sales and marketing campaign for HPV DNA testing kits and making important progress to register products for distribution to female patients at hospitals nationwide. The Medical Centers Management segment engages in the provision of healthcare services for residents living in cities. The Individualized Target Therapy segment specializes in molecular diagnostic kits for leukemia, lymphoma and individualised target cancer therapy. The Bio-Drugs segment engages in the development, production and commercialization of a new generation of non-specific nanotechnology immunomodulatory drugs known as non-cell Corynebacterium pavum products. The company was founded on May 8, 1989 and is headquartered in Hong Kong. | Health Technology |
Shanghai Mingyuan Enterprise Group Co. Ltd. | |
China Association of Health Education | |
Eastern China Health Education Research Society | |
Shanghai Corporate Health Management Promotion Committee |
- Bolsa de valores
- Insiders
- Ti Jun Yu